HSANZ Free Communications 8: BMT / Cellular Therapies
Tracks
HSANZ
| Tuesday, November 7, 2023 |
| 10:30 AM - 12:00 PM |
| Meeting room 216 |
Speaker
Dr Sarah Tan
Bone Marrow Transplant Fellow
Melbourne Health
Total body irradiation-based myeloablative T-cell-replete haploidentical stem cell transplantation: a single institution experience
10:30 AM - 10:45 AMBiography
Dr Sarah Tan completed her physician training and haematology specialist training in New Zealand. She holds dual Fellowships with the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. She currently works as a Bone Marrow Transplant Fellow at Royal Melbourne Hospital/Peter Mac.
Dr Ray Mun Koo
Bone Marrow Transplant Fellow
Melbourne Health
The addition of ATG to reduced-intensity conditioning transplantation from a matched unrelated donor results in similar GRFS but increased TRM when compared to T cell replete matched sibling donor transplantation
10:45 AM - 11:00 AMBiography
Ray is a dual-trained Haematologist and PhD Candidate, currently undertaking a Bone Marrow Transplant Fellowship at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre. The title of his PhD is "Immune Reconstitution Following Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation".
His PhD is supported by an HSANZ / Leukaemia Foundation scholarship.
Dr Nirija Ranjit Anderson
Clinical Haematology Fellow
Queensland Health
Quantifying treatment burden of cytomegalovirus reactivation following allogeneic haematopoietic stem cell transplantation.
11:00 AM - 11:15 AMBiography
Dr Niri Anderson is an early career clinical haematologist, having completed her advanced training in clinical haematology in 2022. She is currently a clinical research fellow at the Princess Alexandra Hospital, where she focuses on amyloidosis and myeloma. She is also an MPhil candidate with the University of Queensland.
Dr James Schwarer
Registrar
Alfred Hospital
Use of haplo-identical donor stem cells increase the risk of CMV reactivation in patients receiving post-transplant cyclophosphamide for GVHD prophylaxis
11:15 AM - 11:30 AMBiography
James is a 1st year haematology trainee with an interest in malignant haematology.
Dr Thomas Lew
Haematology Fellow
Peter MacCallum Cancer Centre / Royal Melbourne Hospital
Allogeneic stem cell transplantation achieves long-term remissions in patients with mantle cell lymphoma, including TP53-mutated disease
11:30 AM - 11:45 AMBiography
Haematology advanced trainee and PhD candidate with interest in CLL, lymphoma and discovery of novel therapies
Dr Christopher Heydon
Registrar
Te Whatu Ora Health New Zealand
Allogeneic haematopoietic stem cell transplant patients in the intensive care unit – a ten year retrospective cohort study
11:45 AM - 12:00 PMBiography
Dr Christopher Heydon is a final year advanced trainee in General Medicine at Wellington Regional Hospital.
Chairperson
Lynette Chee
Haematologist
The Royal Melbourne Hospital/ Peter MacCallum Cancer Centre
David Curtis
Haematologist and BMT Physician
Alfred Health / Monash University
